Growth Metrics

InspireMD (NSPR) Cash from Operations Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -7.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 132.40%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -35.67%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -84.38%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 185.96%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 16.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.60%
10 InspireMD 64.01 Mn 9.80 Mn 1.18 Mn -38.44%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -38.44%
Sep 30, 2025 -51.46%
Jun 30, 2025 -91.39%
Mar 31, 2025 -73.62%
Dec 31, 2024 -61.60%
Sep 30, 2024 -40.98%
Jun 30, 2024 -30.95%
Mar 31, 2024 -4.82%
Dec 31, 2023 -30.74%
Sep 30, 2023 20.79%
Jun 30, 2023 -6.95%
Mar 31, 2023 -16.86%
Dec 31, 2022 -10.13%
Sep 30, 2022 -23.29%
Jun 30, 2022 -22.98%
Mar 31, 2022 -13.54%
Dec 31, 2021 -31.86%
Sep 30, 2021 -36.01%
Jun 30, 2021 -70.47%
Mar 31, 2021 -54.67%
Dec 31, 2020 -40.31%
Sep 30, 2020 -63.66%
Jun 30, 2020 48.81%
Mar 31, 2020 32.45%
Dec 31, 2019 13.03%
Sep 30, 2019 -1.69%
Jun 30, 2019 -32.04%
Mar 31, 2019 -95.79%
Dec 31, 2018 -1.58%
Sep 30, 2018 8.91%
Jun 30, 2018 -37.99%
Mar 31, 2018 35.46%
Dec 31, 2017 5.64%
Sep 30, 2017 32.05%
Jun 30, 2017 -100.25%
Mar 31, 2017 -47.88%
Dec 31, 2016 15.16%
Jun 30, 2016 67.23%
Mar 31, 2016 59.65%
Mar 31, 2015 -24.62%
Mar 31, 2014 -31.66%
Sep 30, 2013 -38.88%
Mar 31, 2013 -78.40%
Dec 31, 2012 18.35%
Sep 30, 2012 -14.09%
Mar 31, 2012 -337.40%
Dec 31, 2011 -658.45%
Sep 30, 2011 -122.04%